Candida albicans proteinases: resolving the mystery of a gene family

References

1. Beausejour A., Grenier D., Goulet J. P., Deslauriers N. 1998; Proteolytic activation of the interleukin-1β precursor by Candida albicans . Infect Immun 66:676–681
   [Google Scholar]
2. Beggah S., Lechenne B., Reichard U., Foundling S., Monod M. 2000; Intra- and intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase Sap1p. Microbiology 146:2765–2773
   [Google Scholar]
3. Borg-von Zepelin M., Beggah S., Boggian K., Sanglard D., Monod M. 1998; The expression of the secreted aspartic proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 28:543–554 [CrossRef]
   [Google Scholar]
4. Borg-von Zepelin M., Meyer I., Thomssen R., Telenti A., Monod M., Würzner R., Sanglard D. 1999; HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Investig Dermatol 113:747–751 [CrossRef]
   [Google Scholar]
5. Caro L. H., Tettelin H., Vossen J. H., Ram A. F., Klis F. M., van den Ende H. 1997; In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae . Yeast 13:1477–1489 [CrossRef]
   [Google Scholar]
6. Cassone A., De Bernardis F., Torosantucci A., Tacconelli E., Tumbarello M., Cauda R. 1999; In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180:448–453 [CrossRef]
   [Google Scholar]
7. De Bernardis F., Cassone A., Sturtevant J., Calderone R. 1995; Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun 63:1887–1892
   [Google Scholar]
8. De Bernardis F., Boccanera M., Adriani D., Spreghini E., Santoni G., Cassone A. 1997; Protective role of antimannan and anti-aspartic proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 65:3399–3405
   [Google Scholar]
9. De Bernardis F., Arancia S., Morelli L., Hube B., Sanglard D., Schäfer W., Cassone A. 1999; Evidence that members of the secretory aspartic proteinase gene family, in particular SAP2 , are virulence factors for Candida vaginitis. J Infect Dis 179:201–208 [CrossRef]
   [Google Scholar]
10. Dubois N., Colina A. R., Aumont F., Belhumeur P., de Repentigny L. 1998; Overexpression of Candida albicans secretory aspartic proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice. Microbiology 144:2299–2310 [CrossRef]
    [Google Scholar]
11. Ernst J. F. 2000; Transcription factors in Candida albicans – environmental control of morphogenesis. Microbiology 146:1763–1774
    [Google Scholar]
12. Fallon K., Bausch K., Noonan J., Huguenel E., Tamburini P. 1997; Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Immun 65:551–556
    [Google Scholar]
13. Fidel P. L., Vazquez J. A., Sobel J. D. 1999; Candida glabrata : review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans . Clin Microbiol Rev 12:80–96
    [Google Scholar]
14. Gilfillan G. D., Sullivan D. J., Haynes K., Parkinson T., Coleman D. C., Gow N. A. 1998; Candida dubliniensis : phylogeny and putative virulence factors. Microbiology 144:829–838 [CrossRef]
    [Google Scholar]
15. Gruber A., Berlit J., Speth C., Lass-Florl C., Kofler G., Nagl M., Borg-von Zepelin M., Dierich M. P., Würzner R. 1999; Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. Immunobiology 201:133–144 [CrossRef]
    [Google Scholar]
16. Hube B. 1996; Candida albicans secreted aspartic proteinases. Curr Top Med Mycol 7:55–69
    [Google Scholar]
17. Hube B. 1998; Possible role of proteinases in Candida infections. Rev Iberoam Micol 15:68–71
    [Google Scholar]
18. Hube B. 2000; Extracellular proteinases of human pathogenic fungi. Contrib Microbiol 5:126–137
    [Google Scholar]
19. Hube B., Turver C. J., Odds F. C., Eiffert H., Boulnois G. J., Köchel H., Rüchel R. 1991; Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J Med Vet Mycol 29:129–132 [CrossRef]
    [Google Scholar]
20. Hube B., Monod M., Schofield D. A., Brown A. J., Gow N. A. 1994; Expression of seven members of the gene family encoding secretory aspartic proteinases in Candida albicans . Mol Microbiol 14:87–99 [CrossRef]
    [Google Scholar]
21. Hube B., Sanglard D., Odds F. C., Hess D., Monod M., Gow N. A., Schäfer W., Brown A. J. 1997; Disruption of each of the secreted aspartic proteinase genes SAP1 , SAP2 , and SAP3 of Candida albicans attenuates virulence. Infect Immun 65:3529–3538
    [Google Scholar]
22. Ibrahim A. S., Filler S. G., Sanglard D., Edwards J. E. Jr, Hube B. 1998; Secreted aspartic proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun 66:3003–3005
    [Google Scholar]
23. Jarvis W. R. 1995; Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530 [CrossRef]
    [Google Scholar]
24. Kaminishi H., Hamatake H., Cho T., Tamaki T., Suenaga N., Fujii T., Hagihara Y., Maeda H. 1994; Activation of blood clotting factors by microbial proteinases. FEMS Microbiol Lett 121:327–332 [CrossRef]
    [Google Scholar]
25. Koelsch G., Tang J., Loy J. A., Monod M., Jackson K., Foundling S. I., Lin X. 2000; Enzymic characteristics of secreted aspartic proteases of Candida albicans . Biochim Biophys Acta 1480117–131 [CrossRef]
    [Google Scholar]
26. Komano H., Rockwell N., Wang G. T., Krafft G. A., Fuller R. S. 1999; Purification and characterization of the yeast glycosylphosphatidylinositol-anchored, monobasic-specific aspartyl protease yapsin 2 (Mkc7p). J Biol Chem 274:24431–24437 [CrossRef]
    [Google Scholar]
27. Korting H. C., Schaller M., Eder G., Hamm G., Böhmer U., Hube B. 1999; Effects of the human immunodefiency virus (HIV) proteinase inihibitors saquinavir and indinavir on the in vitro activities of secreted aspartic proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother 43:2038–2042
    [Google Scholar]
28. Kretschmar M., Hube B., Bertsch T., Sanglard D., Merker R., Schroder M., Hof H., Nichterlein T. 1999; Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun 67:6637–6642
    [Google Scholar]
29. Kvaal C., Lachke S. A., Srikantha T., Daniels K., McCoy J., Soll D. R. 1999; Misexpression of the opaque-phase-specific gene PEP1 ( SAP1 ) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun 67:6652–6662
    [Google Scholar]
30. Magee B. B., Hube B., Wright R. J., Sullivan P. J., Magee P. T. 1993; The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members. Infect Immun 618:3240–3243
    [Google Scholar]
31. Miyasaki S. H., White T. C., Agabian N. 1994; A fourth secreted aspartic proteinase gene ( SAP4 ) and a CARE2 repetitive element are located upstream of the SAP1 gene in Candida albicans . J Bacteriol 176:1702–1710
    [Google Scholar]
32. Monod M., Togni G., Hube B., Sanglard D. 1994; Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13:357–368 [CrossRef]
    [Google Scholar]
33. Monod M., Hube B., Hess D., Sanglard D. 1998; Differential regulation of SAP8 and SAP9 , which encode two new members of the secreted aspartic proteinase family in Candida albicans . Microbiology 144:2731–2737 [CrossRef]
    [Google Scholar]
34. Monod M., Jaton-Ogay K., Reichard U. 1999; Aspergillus fumigatus -secreted proteases as antigenic molecules and virulence factors. Contrib Microbiol 2:182–192
    [Google Scholar]
35. Morrow B., Srikantha T., Soll D. R. 1992; Transcription of the gene for a pepsinogen, PEP1 , is regulated by white-opaque switching in Candida albicans . Mol Cell Biol 12:2997–3005
    [Google Scholar]
36. Naglik J. R., Newport G., White T. C., Fernandes-Naglik L. L., Greenspan J. S., Greenspan D., Sweet S. P., Challacombe S. J., Agabian N. 1999; In vivo analysis of secreted aspartic proteinase expression in human oral candidiasis. Infect Immun 67:2482–2490
    [Google Scholar]
37. Neely A. N., Miller R. G., Holder I. A. 1994; Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition. Infect Immun 62:2158–2164
    [Google Scholar]
38. Newport G., Agabian N. 1997; KEX2 influences Candida albicans proteinase secretion and hyphal formation. J Biol Chem 272:28954–28961 [CrossRef]
    [Google Scholar]
39. Odds F. C. 1994; Candida species and virulence. ASM News 60:313–318
    [Google Scholar]
40. Rüchel R. 1992; Proteinase. In New Strategies in Fungal Disease pp 17–31 Edited by Bennett J. E., Hay R. J., Peterson P. K. Edinburgh: Churchill Livingstone;
    [Google Scholar]
41. Rüchel R., Zimmermann F., Böning-Stutzer B., Helmchen U. 1991; Candidosis visualised by proteinase-directed immunofluorescence. Virchows Arch A Pathol Anal Histopathol 419:199–202 [CrossRef]
    [Google Scholar]
42. Sanglard D., Hube B., Monod M., Odds F. C., Gow N. A. 1997; A triple deletion of the secreted aspartic proteinase genes SAP4 , SAP5 , and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 65:3539–3546
    [Google Scholar]
43. Schaller M., Hube B., Schäfer W., Korting H. C. 1998; Differential expression of secreted aspartic proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 29:605–615 [CrossRef]
    [Google Scholar]
44. Schaller M., Hube B., Ollert M. W., Thoma-Greber E., Korting H. C., Schäfer W., Borg-von Zepelin M. 1999a; In vivo expression and localization of Candida albicans secreted aspartic proteinases during oral candidosis in HIV-infected patients. J Investig Dermatol 112:383–386 [CrossRef]
    [Google Scholar]
45. Schaller M., Korting H. C., Chen W., Hube B., Schäfer W., Bastert J. 1999b; Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34:169–180 [CrossRef]
    [Google Scholar]
46. Schaller M., Schackert C., Korting H. C., Januschke E., Hube B. 2000; Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Investig Dermatol 114:712–717 [CrossRef]
    [Google Scholar]
47. Schröppel K., Sprosser K., Whiteway M., Thomas D. Y., Röllinghoff M., Csank C. 2000; Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase cpp1p of Candida albicans is independent of the MAP kinase cek1p. Infect Immun 68:7159–7161 [CrossRef]
    [Google Scholar]
48. Sobel J. D. 1985; Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 152:924–935 [CrossRef]
    [Google Scholar]
49. Smolenski G., Sullivan P. A., Cutfield S. M., Cutfield J. F. 1997; Analysis of secreted aspartic proteinases from Candida albicans : purification and characterization of individual Sap1, Sap2 and Sap3 isoenzymes. Microbiology 143:349–356 [CrossRef]
    [Google Scholar]
50. Soll D. R. 1997; Gene regulation during high-frequency switching in Candida albicans . Microbiology 143:279–288 [CrossRef]
    [Google Scholar]
51. Staib F. 1965; Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia 4:187–193
    [Google Scholar]
52. Staib P., Kretschmar M., Nichterlein T., Hof H., Hacker J., Köhler G., Michel S., Morschhäuser J. 1999; Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol 32:533–546 [CrossRef]
    [Google Scholar]
53. Staib P., Kretschmar M., Nichterlein T., Hof H., Morschhäuser J. 2000; Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci USA 97:6102–6107 [CrossRef]
    [Google Scholar]
54. Stehr F., Felk A., Kretschmar M., Schaller M., Schafer W., Hube B. 2000; Extracellular hydrolytic enzymes and their relevance during Candida albicans infections. Mycoses 43, Suppl. 2:17–21
    [Google Scholar]
55. Togni G., Sanglard D., Quadroni M., Foundling S. I., Monod M. 1996; Acid proteinase secreted by Candida tropicalis : functional analysis of preproregion cleavages in C. tropicalis and Saccharomyces cerevisiae . Microbiology 142:493–503 [CrossRef]
    [Google Scholar]
56. Tsushima H., Mine H. 1995; Cleavage of human big endothelin-1 by Candida albicans aspartic proteinase. FEMS Immunol Med Microbiol 11:69–72 [CrossRef]
    [Google Scholar]
57. Tsushima H., Mine H., Kawakami Y., Hyodoh F., Ueki A. 1994; Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 140:167–171 [CrossRef]
    [Google Scholar]
58. Watts H. J., Cheah F. S., Hube B., Sanglard D., Gow N. A. 1998; Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol Lett 159:129–135 [CrossRef]
    [Google Scholar]
59. White T. C., Agabian N. 1995; Candida albicans secreted aspartic proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 177:5215–5221
    [Google Scholar]
60. White T. C., Miyasaki S. H., Agabian N. 1993; Three distinct secreted aspartic proteinases in Candida albicans . J Bacteriol 175:6126–6133
    [Google Scholar]
61. Wright R. J., Carne A., Hieber A. D., Lamont I. L., Emerson G. W., Sullivan P. A. 1992; A second gene for a secreted aspartate proteinase in Candida albicans . J Bacteriol 174:7848–7853
    [Google Scholar]
62. Zaugg C., Borg-Von Zepelin M., Reichard U., Sanglard D., Monod M. 2001; Secreted aspartic proteinase family of Candida tropicalis . Infect Immun 69:405–412 [CrossRef]
    [Google Scholar]